HeyJaredDiagnostics World News
Diagnostics World News is a specialized digital news outlet focused on the science, technology, and business of medical diagnostics.
- Indexed articles, last 90 days
- 9
- Latest publication
- Jul 29, 2026
- Audience
- Top 50M sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Follow the Money: Novel NeuroAI Model, Autoimmune, Inflammatory Disease Treatment, Drug Discovery (opens the original)
Read excerpt
Diagnostics World | Fresenius expands its access to innovation networks through its own corporate venture capital fund over the next five years; Transcripta Bio's closed-loop discovery engine is designed to use transcriptomic signature matching to identify drugs whose molecular signatures are the inverse of patient-derived disease signatures; and more.
Approaching Diagnostic Development with Scalability, Regulatory Readiness, and Long-Term Success in Mind (opens the original)
Read excerpt
Diagnostics World | Growing momentum in biomarker discovery, advancing analytical technologies, and a shift toward personalized medicine have created unprecedented possibilities for diagnostic development. The pace at which this progress translates to novel, widely adopted, clinically validated diagnostic tools remains slow, but not for lack of innovation.
Vibrating Pill Could Both Treat Eating Disorders and Predict Relapse (opens the original)
Read excerpt
Diagnostics World | Digestive sensations profoundly affect mental health through the bidirectional gut-brain axis, and in the case of anorexia nervosa (AN) tends to do so at crisis proportions. The disorder has one of the highest mortality rates of any psychiatric disorder with suicide being the leading cause of death.
Nanotechnology for Point-of-Care Screening of Gut Health (opens the original)
Read excerpt
Diagnostics World | Indole-3-propionic acid (IPA) is increasingly recognized as a critical chemical shield and promising biomarker for gut inflammation. Levels of IPA are starkly deficient in the blood of patients with active ulcerative colitis (UC), but the gold standard measurement technique of liquid chromatography-mass spectrometry (LC-MS) is costly and requires highly trained technicians to run the equipment, limiting its use to specialized research cohorts and clinical trials.
Epi One Aims to ‘Democratize’ Early Detection One Cancer at a Time (opens the original)
Read excerpt
Diagnostics World | Much like the trajectory of infectious disease diagnostics was changed by PCR and molecular methods, Epi One is looking to alter the course of cancer diagnostics with direct, highly sensitive molecular detection of specific epigenetic biomarkers of multiple malignancies. First out of the gate will be a prostate cancer re-biopsy decision tissue-based assay, immediately followed by an initial prostate cancer biopsy blood-based test.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50M sites
Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.